Page 5,201«..1020..5,2005,2015,2025,203..5,2105,220..»

BrainStorm Receives 1.2 Million NIS Grant From Israel's Office of the Chief Scientist

Posted: Published on June 4th, 2013

NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwired - Jun 4, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the Company has received the third installment of the 2013 grant from Israel's Office of the Chief Scientist (OCS) in the amount of approximately $335,000 (~1.2M NIS). The yearly grant for 2013, in the amount of $729,000 (~2.7M NIS), was awarded to BrainStorm's Research and Development program towards the development of its leading and innovative NurOwn therapy for ALS using autologous adult stem cells. "We are thankful to the OCS for its continued support of our NurOwn R&D program. The non-dilutive funding we receive from them will support our efforts to expedite our clinical development program as well as optimization of the NurOwn manufacturing process," said Alon Natanson, BrainStorm's CEO. The OCS has supported BrainStorm Cell Therapeutics Ltd. since 2007, providing a total of $2.67 million in grants, including this one. Under the terms of the grant, the Company is required to pay royalties to the OCS, amounting to 3% - 5% of revenues derived from sales of the products funded with these grants, but only up to the … Continue reading →

Comments Off on BrainStorm Receives 1.2 Million NIS Grant From Israel's Office of the Chief Scientist

20. Health Ministry: Registry on practitioners of aesthetic medicine to be set up

Posted: Published on June 4th, 2013

SEREMBAN: A national registry on doctors and specialists in aesthetic medicine will be set up to curb allegations of disfigurements or deaths arising from aesthetic procedures performed by incompetent medical and non-medical practitioners. Medical and surgical specialists will be required to possess a higher qualification and be properly trained in their respective fields before they can have their names included in the National Registry of Registered Medical Practitioners Practising Aesthetic Medical Practice. These are among new provisions introduced by the Health Ministry in a move to regulate the industry following a significant increase in the number of doctors engaging in this practice. Health director-general Datuk Dr Noor Hisham Abdullah said the main objective of the registry was to ensure the safety of aesthetic medical practice in Malaysia. In recent years, aesthetic medical practice has gained popularity and as it is a consumer-driven service, the public needs to be protected. Aesthetic medical practice is not risk-free as many may perceive. In the pursuit of trying to satisfy the aesthetic desires of patients, practitioners need to be aware of the health risks and potential complications, he said in the foreword of the just-released Guidelines on Aesthetic Medical Practice for Registered Medical Practitioners … Continue reading →

Posted in Aesthetic Medicine | Comments Off on 20. Health Ministry: Registry on practitioners of aesthetic medicine to be set up

Health Ministry: Registry on practitioners of aesthetic medicine to be set up

Posted: Published on June 4th, 2013

SEREMBAN: A national registry on doctors and specialists in aesthetic medicine will be set up to curb allegations of disfigurements or deaths arising from aesthetic procedures performed by incompetent medical and non-medical practitioners. Medical and surgical specialists will be required to possess a higher qualification and be properly trained in their respective fields before they can have their names included in the National Registry of Registered Medical Practitioners Practising Aesthetic Medical Practice. These are among new provisions introduced by the Health Ministry in a move to regulate the industry following a significant increase in the number of doctors engaging in this practice. Health director-general Datuk Dr Noor Hisham Abdullah said the main objective of the registry was to ensure the safety of aesthetic medical practice in Malaysia. In recent years, aesthetic medical practice has gained popularity and as it is a consumer-driven service, the public needs to be protected. Aesthetic medical practice is not risk-free as many may perceive. In the pursuit of trying to satisfy the aesthetic desires of patients, practitioners need to be aware of the health risks and potential complications, he said in the foreword of the just-released Guidelines on Aesthetic Medical Practice for Registered Medical Practitioners … Continue reading →

Posted in Aesthetic Medicine | Comments Off on Health Ministry: Registry on practitioners of aesthetic medicine to be set up

CLVS Zooms To New High, FLML Gets Thumbs Up, SNTA Dives, STEM Grows

Posted: Published on June 4th, 2013

By RTT News, June 04, 2013, 12:58:00 AM EDT (RTTNews.com) - AbbVie Inc. ( ABBV ) on Monday announced that its investigational oncology compound ABT-199, developed in partnership with Genentech, has demonstrated potential in treating patients with relapsed/refractory chronic lymphocytic leukemia, or CLL, in a phase I study. The company's amended clinical trial protocols for studies of ABT-199 in patients with CLL were recently accepted by the FDA and enrollment for ABT-199 clinical trials in CLL, NHL and multiple myeloma has been re-instated. AbbVie and Genentech expect to move ABT-199 into later-stage clinical trials in the near future. ABBV closed Monday's trading 1.57% higher at $43.36. Biologix Hair Inc. ( BLGX ) rose over 9% on Monday after the company announced that its network has expanded from 196 clinics at the time of inception to 276 clinics through the end of April 2013. During the same period, the number of countries in which clinicians has been contracted has increased from 11 to 37. BioTime Inc. ( BTX ) has offered to sell up to an aggregate of 2,180,016 common shares and 545,004 warrants to purchase common shares, in "units" with each unit consisting of one common share and one-quarter of … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on CLVS Zooms To New High, FLML Gets Thumbs Up, SNTA Dives, STEM Grows

FDA suspends Pluristem stem cell study

Posted: Published on June 4th, 2013

The US Food and Drug Administration (FDA) has suspended a Phase II clinical trial by Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) of its placental stem study for the treatment of intermittent claudication (calf muscle pain). The clinical hold was place after a patient suffered a serious allergic reaction which required hospitalization. Pluristem said that this was the first serious allergic event among the 74 patients enrolled in the company's clinical trials to date. It added, "This event occurred in a patient with multiple diseases which may have influenced the severity of the event. The patient was discharged from the hospital the following day, following the resolution of all her symptoms." The FDA will issue a letter within the next 30 days detailing a list of questions and requests for information from Pluristem. Pluristem chairman and CEO Zami Aberman said, "Once we receive the letter, we will work closely with the FDA to address all issues raised. We are committed to our strategy that our competitive technology advantage be involved in clinical programs for multiple indications." Published by Globes [online], Israel business news - http://www.globes-online.com - on June 4, 2013 Copyright of Globes Publisher Itonut (1983) Ltd. 2013 Read the … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on FDA suspends Pluristem stem cell study

Stem Cell Therapeutics' Clinical Advisor and Collaborator Receives Prestigious National Award

Posted: Published on June 4th, 2013

TORONTO, ONTARIO--(Marketwired - Jun 4, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics, today announced that Dr. Aaron Schimmer has been awarded a prestigious national award for his groundbreaking cancer research for the second time in approximately a year. Each year, the Canadian Cancer Society honours four exceptional Canadian scientists who have made significant contributions to progress in cancer research. This year, Dr. Schimmer is the recipient of the Bernard and Francine Dorval Prize, which is awarded to a promising investigator who began their independent research within the previous 10 years and who has made outstanding contributions to basic biomedical research. In 2012, Dr. Schimmer received the Till & McCulloch Award, presented each year by the Stem Cell Network in recognition of the year's most influential peer-reviewed article by a researcher in Canada. Dr. Schimmer's laboratory is investigating the repurposing of several FDA-approved drugs with favourable pharmacokinetic and toxicological properties for use as novel anticancer agents. One of these drugs is tigecycline, a broad-spectrum antibiotic. Stem Cell Therapeutics ("SCT") recently acquired exclusive worldwide rights to an innovative clinical cancer stem cell program based on Dr. Schimmer's discovery that tigecycline targets and … Continue reading →

Comments Off on Stem Cell Therapeutics' Clinical Advisor and Collaborator Receives Prestigious National Award

Transition 11.5 weeks on testosterone! – Video

Posted: Published on June 4th, 2013

Transition 11.5 weeks on testosterone! Just some random life updates of my testosterone adventure. By: hayden13jesse … Continue reading →

Posted in Testosterone | Comments Off on Transition 11.5 weeks on testosterone! – Video

5 months on testosterone (ungodly long edition) – Video

Posted: Published on June 4th, 2013

5 months on testosterone (ungodly long edition) here, have a really long update since i haven't been quite diligent in recent weeks/months/uhhh... apologies in advance for the lag, our internet is kind of derpy. in this video, i ramble... By: Arthur Scoleri … Continue reading →

Posted in Testosterone | Comments Off on 5 months on testosterone (ungodly long edition) – Video

top surgery and testosterone update – Video

Posted: Published on June 4th, 2013

top surgery and testosterone update showing my chest after one year, talking about starting testosterone. By: alex burke … Continue reading →

Posted in Testosterone | Comments Off on top surgery and testosterone update – Video

Men in Red: Higher Testosterone Levels, Study Finds

Posted: Published on June 4th, 2013

FRIDAY, May 31 (HealthDay News) -- Male athletes who choose to wear the color red in competition have higher levels of the male hormone testosterone than men who pick the color blue, a British study suggests. Men who wear red could be sending an unconscious signal about their competitiveness to their opponents, the researchers suggested in the study, which is to be published in an upcoming issue of the journal Psychological Science. "The research shows that there is something special about the color red in competition, and that it is associated with our underlying biological systems," study leader Daniel Farrelly, a psychological scientist at the University of Sunderland, said in a news release from the Association for Psychological Science. The researchers pointed out their findings may help explain why many high-profile athletes, such as golf great Tiger Woods, wear red clothing. In conducting the study, the researchers told 73 men they would be completing a competitive task and their performance would be posted. The men were asked to choose between a red or blue symbol to represent themselves in the competition. They also answered questionnaires to help determine why they may have chosen one color over the other. The researchers … Continue reading →

Posted in Testosterone | Comments Off on Men in Red: Higher Testosterone Levels, Study Finds

Page 5,201«..1020..5,2005,2015,2025,203..5,2105,220..»